BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang T, Liu L, Liu W. Network pharmacology-based strategy for predicting therapy targets of Tripterygium wilfordii on acute myeloid leukemia. Medicine (Baltimore) 2020;99:e23546. [PMID: 33327305 DOI: 10.1097/MD.0000000000023546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Z, Yuan ZZ, Ma XL. Network Pharmacology-Based Strategy and Molecular Docking to Explore the Potential Mechanism of Jintiange Capsule for Treating Osteoporosis. Evid Based Complement Alternat Med 2021;2021:5338182. [PMID: 34899951 DOI: 10.1155/2021/5338182] [Reference Citation Analysis]
2 Du HX, Zhu JQ, Chen J, Zhou HF, Yang JH, Wan HT. Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology. Aging (Albany NY) 2021;13:14571-89. [PMID: 34088885 DOI: 10.18632/aging.203098] [Reference Citation Analysis]
3 Jin Y, Wang Y, Wang S, Zhao Q, Zhang D, Feng X. The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children. Evid Based Complement Alternat Med 2021;2021:7223613. [PMID: 34721642 DOI: 10.1155/2021/7223613] [Reference Citation Analysis]
4 Liu T, Cao X, Cao D. Combination of UHPLC-Q Exactive-Orbitrap MS and network pharmacology to reveal the mechanism of Eucommia ulmoides leaves in the treatment of osteoarthritis. J Food Biochem 2022;:e14204. [PMID: 35484881 DOI: 10.1111/jfbc.14204] [Reference Citation Analysis]